• Policy & Insight

2024 in review - 7 significant steps forward for cancer policy

It's been a busy year for the policy team at Cancer Research UK! From campaigning for tobacco control to working internationally to beat cervical cancer, here are seven policy highlights from 2024. It's been a busy year for the policy team at Cancer Research UK! From campaigning for tobacco control to working internationally to beat cervical cancer, here are seven policy highlights from 2024.

27 December 2024

• Health & Medicine

Almost 90,000 cancer cases caught by screening over last five years

New data analysis from our Cancer Intelligence team has shown that around 89,800 cancer cases have been detected by the three national screening programmes in England in the last five years New data analysis from our Cancer Intelligence team has shown that around 89,800 cancer cases have been detected by the three national screening programmes in England in the last five years

19 December 2024

• Policy & Insight

What role can NHS scientists play in delivering the genomic revolution?

Alice Hilborn, policy advisor at Cancer Research UK, sits down with David Wells, chief executive at the Institute of Biomedical Science (IBMS), to understand the views of the IBMS on the future of genomic medicine, and the role healthcare scientists could play. Alice Hilborn, policy advisor at Cancer Research UK, sits down with David Wells, chief executive at the Institute of Biomedical Science (IBMS), to understand the views of the IBMS on the future of genomic medicine, and the role healthcare scientists could play.

10 December 2024

• Policy & Insight

Autumn statement 2024: What does the budget mean for cancer?

Today was the first budget from the new Chancellor, Rachel Reeves. Here, we take a look at what the autumn statement means for cancer. Today was the first budget from the new Chancellor, Rachel Reeves. Here, we take a look at what the autumn statement means for cancer.

31 October 2024

• Policy & Insight

What did party conference season mean for cancer?

Ian Caleb, public affairs manager, reviews the Liberal Democrat, Labour and Conservative party conferences and explains what they mean for cancer. Ian Caleb, public affairs manager, reviews the Liberal Democrat, Labour and Conservative party conferences and explains what they mean for cancer.

4 October 2024

• Health & Medicine

300,000 won’t start cancer treatment on time if waiting times don't improve

With 300,000 people set to wait longer than they should for treatment over the next five years, the new government needs to improve cancer waiting times performance.  With 300,000 people set to wait longer than they should for treatment over the next five years, the new government needs to improve cancer waiting times performance. 

20 September 2024

• Policy & Insight

How Secure Data Environments can help drive advances in health data research

NHS England is changing the way that researchers access health data in England by moving to a network of Secure Data Environments. With proper government support, it can help researchers find better ways to prevent, diagnose and treat cancer. NHS England is changing the way that researchers access health data in England by moving to a network of Secure Data Environments. With proper government support, it can help researchers find better ways to prevent, diagnose and treat cancer.

8 August 2024

• Policy & Insight

Why a focus on waiting time targets may neglect the poorest cancer patients

Naser Turabi, our director of evidence and implementation, explains why ensuring equitable access to cancer treatment is so crucial. Naser Turabi, our director of evidence and implementation, explains why ensuring equitable access to cancer treatment is so crucial.

22 July 2024

• Policy & Insight

Leading on Cancer: Why the next UK Government must set out a new strategy for cancer

We outline some of the highlights from our new report 'Leading on Cancer' where we set out the evidence on the role that cancer control strategies can play in improving cancer outcomes We outline some of the highlights from our new report 'Leading on Cancer' where we set out the evidence on the role that cancer control strategies can play in improving cancer outcomes

19 June 2024

• Policy & Insight

This election must be a turning point for cancer

Michelle Mitchell, our chief executive, explains why the upcoming general election must be a turning point for cancer Michelle Mitchell, our chief executive, explains why the upcoming general election must be a turning point for cancer

18 June 2024